LINDSEY BOFINGER: Open Payments
NPI 1902274988 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$650 in 25 payments from 9 companies in 2025. Trend: 2023 $26 · 2024 $101 · 2025 $650
Food & beverage: $650
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 5 | $160 |
| Lilly USA, LLC | 2 | $152 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $151 |
| Alkermes, Inc. | 4 | $80 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| ABBVIE INC. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $18 |
Products named: Jornay PM, CAPLYTA, ZEPBOUND, ARISTADA, SPRAVATO, Auvelity, UBRELVY, ABILIFY ASIMTUFII.
Industry payments across LA — which companies pay providers there.
